Humacyte, Inc.·4

May 15, 7:24 PM ET

Binder Gordon M 4

4 · Humacyte, Inc. · Filed May 15, 2024

Insider Transaction Report

Form 4
Period: 2024-05-15
Transactions
  • Purchase

    Common Stock

    2024-05-15$6.78/sh+50,000$339,000160,000 total
  • Purchase

    Common Stock

    2024-05-15$6.57/sh+50,000$328,50050,000 total(indirect: By Trust)
Footnotes (2)
  • [F1]The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.44 to $6.59. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.64 to $6.96. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    wk-form4_1715815434.xmlPrimary

    FORM 4